NCT01595022View on ClinicalTrials.gov

FR01 and FR20 IUS (Intrauterine System) Wearing Study

PHASE1CompletedINTERVENTIONAL
Enrollment

90

Participants

Timeline

Start Date

January 31, 2010

Primary Completion Date

September 30, 2010

Study Completion Date

September 30, 2010

Conditions
Contraception
Interventions
DRUG

Placebo: Flexi ring FR01

Intrauterine device, inserted once for 3 months

DRUG

Placebo: Flexi ring FR20

Intrauterine device, inserted once for 3 months

DRUG

Placebo: Ultra low dose levonorgestrel contraceptive system (LCS)

Intrauterine device, inserted once for 3 months

Trial Locations (10)

20100

Turku

33100

Tampere

70110

Kuopio

75185

Uppsala

00100

Helsinki

1780 AT

Den Helder

6401 CX

Heerlen

3331 LZ

Zwijndrecht

701 85

Örebro

171 76

Stockholm

Sponsors

Lead Sponsor

Bayer
All Listed Sponsors
lead

Bayer

INDUSTRY